Novel Strategies for Spatiotemporal and Controlled BMP-2 Delivery in Bone Tissue Engineering
Bone morphogenetic protein-2 (BMP-2) has been commercially approved by the Food and Drug Administration for use in bone defects and diseases.BMP-2 promotes osteogenic differentiation of mesenchymal stem cells.In bone tissue engineering, BMP-2 incorporated into scaffolds can be used for stimulating bone regeneration in organoid construction, drug te